Literature DB >> 8354039

Adverse effects of molgramostim in marrow transplant recipients.

C Ippoliti1, D Przepiorka, T Smith, S Maiese, S Giralt, B S Andersson, A B Deisseroth, R E Champlin.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8354039

Source DB:  PubMed          Journal:  Clin Pharm        ISSN： 0278-2677


× No keyword cloud information.
  3 in total

Review 1.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Granulocyte-stimulating factor filgrastim and molgramostim induced recurring encephalopathy and focal status epilepticus.

Authors:  O Kastrup; H C Diener
Journal:  J Neurol       Date:  1997-04       Impact factor: 4.849

Review 3.  Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant.

Authors:  K L Goa; H M Bryson
Journal:  Pharmacoeconomics       Date:  1994-01       Impact factor: 4.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.